Proposed NIH Grant Oversight Plan Was Rescinded
The policy would have allowed political appointees to review research funding, though the plan was ultimately dropped.
Updated on Sept. 24, 2026 in COVID-19
Live Poll
Should political appointees have the authority to veto NIH research grants?
President Donald Trump proposed a plan that would have shifted authority over NIH research grants from established peer-review processes to political appointees. This change followed a broader administration move to cut or freeze $3 billion in research funding during 2025.
Why it matters
The proposal raised significant concerns regarding the independence of federal health research, which currently relies on scientific peer review to determine funding. These actions directly impacted organizations like the Richmond-based company Evizia, which saw its $2.2 million in NIH grant funding delayed.
In 2025, the administration cut or froze $3 billion in NIH research grants, disrupting typical funding cycles. While the shift toward political oversight was proposed, the extent to which this would have altered the peer-review success rate of grant applicants remains unknown.
The players
President Donald Trump
The current President of the United States who proposed and then rescinded the plan for political oversight of NIH research grants.
Evizia
A company based in Richmond, Virginia, that experienced delays in receiving $2.2 million in NIH research grants.
NIH
The agency responsible for national medical research, which currently uses a peer review process to distribute scientific funding.
The details
The NIH currently awards grants through an established peer review process, where scientific experts evaluate proposals based on merit and research potential. The proposed plan would have shifted this authority to political appointees at the White House, allowing them to approve or veto individual projects. This shift would have bypassed the standard scientific evaluation, potentially changing how resources are allocated across the health sector.
Timeline
2025: $3 billion in NIH research grants were cut or frozen by the administration.
2025: Evizia was awarded $2.2 million in NIH grants, which were subsequently delayed.
September 2026: President Trump proposed and later rescinded a plan for White House control over NIH grants.
Health Landscape
This proposal marked a potential departure from the long-standing NIH peer review process by introducing political authority into the grant allocation system. It highlights the vulnerability of scientific research funding to shifting administrative policies at the federal level.
These funding shifts can directly affect the speed and availability of new clinical trials and health innovations being developed by research entities. If you participate in clinical studies or follow specific research developments, talk to your doctor about how local funding changes might affect ongoing trials.
The takeaway
Maintaining independent scientific peer review is critical to ensuring that medical research is prioritized based on clinical need and evidence. Readers should stay informed about federal health policy changes by tracking official announcements from research agencies like the NIH.
Further reading
For more information on the current state of federal health research and funding protocols, visit COVID-19.
Source note: This article includes information reported by 8News.
Live Poll
Should political appointees have the authority to veto NIH research grants?
